Results 161 to 170 of about 51,637 (256)

Change of voltage‐gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model [PDF]

Olena Butenko, Stine Marie Jensen, Yvonne E. Fillié‐Grijpma, Robyn Verpalen, Jan J.G.M. Verschuuren, Silvère M. van der Maarel, Maartje G. Huijbers, Jaap J. Plomp   +7 more
openalex   +1 more source

Myasthenia Gravis [PDF]

Postgraduate Medical Journal, 1939
openaire   +2 more sources

UK Biobank: Transforming drug discovery and precision medicine

British Journal of Pharmacology, Volume 183, Issue 2, Page 234-248, January 2026.
UK Biobank is a large‐scale, prospective study with extensive genetic and phenotypic data on half a million individuals. Volunteers, aged between 40 and 69 years, were recruited between 2006 and 2010 from the general population of the United Kingdom.
Jelena Bešević, Saredo Said, Reka Nagy, Yalda Jamshidi, Christopher D. Whelan, Lauren Carson, Martin K. Rutter, Adam J. Lewandowski, Mark Effingham, Rory Collins, Ben Lacey, Naomi E. Allen   +11 more
wiley   +1 more source

Immune dysregulation driven by elevated platelet-to-lymphocyte ratio aggravates myasthenia gravis. [PDF]

J Int Med Res
Luo S, Song Z, Zhawatibai A, Qiu Y, Li M, Zhu Y, Yu Y, Zhou M, Hong D.   +8 more
europepmc   +1 more source

Myasthenia gravis [PDF]

Canadian Medical Association Journal, 2018
Pierre R, Bourque, Ari, Breiner
openaire   +2 more sources

Transforming Growth Factor‐β1 as a Biomarker of Malignant Behavior and PD‐L1 Expression in Thymic Epithelial Tumors

Cancer Science, Volume 117, Issue 1, Page 181-192, January 2026.
Co‐expression of high TGF‐β1 and PD‐L1 was linked to the poorest prognosis (5‐year FFR: 46.1%) and was identified as an independent predictor of recurrence (adjusted hazard ratio: 7.15; 95% confidence interval: 1.20–42.8) in thymic epithelial tumors. In vitro, TGF‐β1 stimulation upregulated PD‐L1 expression in a dose‐dependent manner, accompanied by ...
Chiaki Nakazono, Satoru Okada, So Tando, Shunta Ishihara, Masanori Shimomura, Tatsuo Furuya, Kenji Kameyama, Stefan Küffer, Denise Müller, Alexander Marx, Satoshi Teramukai, Philipp Ströbel, Kyoko Itoh, Masayoshi Inoue   +13 more
wiley   +1 more source

Urinary dysfunction in myasthenia Gravis: a cross-sectional case-control study. [PDF]

Neurol Sci
Shihada K, Gorenshtein A, Wolfe GI, Shelly S.   +3 more
europepmc   +1 more source

Clinical Features and Outcomes of Ocular Myasthenia Gravis in a Tertiary Philippine Hospital. [PDF]

Acta Med Philipp
Labiano AT, Cruz FMO, Mesina BVQ.
europepmc   +1 more source

Myasthenia Gravis Outcomes After Use of Statins and Other Contraindicated Treatments: Results From the French National Insurance Database

European Journal of Neurology, Volume 33, Issue 1, January 2026.
In this real‐world study among 14,459 adults with MG, exposure to any contraindicated treatment was not significantly associated with risk of ICU admission for MG but was associated with significantly higher risk of death. In contrast, statins were associated with a greater risk of ICU admission but a lower risk of death.
Guilhem Solé, Jean Philippe Camdessanché, Shahram Attarian, Mariana Ciumas, Cécile Blein, Benjamin Grenier, Eléonore Herquelot, Andoni Echaniz‐Laguna   +7 more
wiley   +1 more source

Myasthenia gravis and nutrition. [PDF]

Front Nutr
Uçak MN, Arıtıcı Çolak G.
europepmc   +1 more source